Abstract
Aim: This study aimed to identify the risk factors associated with intra- and postoperative cerebrospinal fluid (CSF) leakage in pituitary adenomas treated by endoscopic transsphenoidal surgery. Methods: A retrospective analysis was conducted on 250 patients who underwent endoscopic endonasal transsphenoidal surgery (EETS) between January 2017 and December 2019. Univariate and multivariate analyses were performed to investigate risk factors for CSF rhinorrhea. Results: Intraoperative and postoperative CSF leakages occurred in 32.0% and 3.6% of patients, respectively. Tumor size was an independent risk factor for intraoperative leakage (OR 1.229, P<0.001). For postoperative leakage, independent risk factors included intraoperative CSF leakage (OR 7.707, P=0.022) and chronic respiratory disease (CRD) (OR 57.500, P<0.001). The use of a vascularized septal mucosal flap was found to be a significant protective factor (OR 0.107, P=0.039). Conclusion: Large pituitary adenomas are more prone to intraoperative CSF leaks, which significantly increase the risk of postoperative rhinorrhea. CRD is a major postoperative risk factor, while vascularized nasal septal flaps (VNSF) effectively mitigate these risks.
Introduction
Endoscopic endonasal transsphenoidal surgery (EETS) has become the gold standard for treating pituitary adenomas due to its minimally invasive nature. However, it carries a persistent and potentially life-threatening risk: cerebrospinal fluid (CSF) rhinorrhea. A leak occurs when the barrier between the brain's fluid and the nasal cavity is breached, opening a doorway for bacteria and leading to complications like meningitis or tension pneumocephalus. While surgical techniques have improved, the specific patient and tumor characteristics that predispose someone to these leaks remain a subject of clinical investigation.
Methods
The researchers conducted a retrospective analysis of 250 patients who underwent EETS at the Second Xiangya Hospital between 2017 and 2019. To ensure consistency, all surgeries were performed by a single experienced surgeon. The team analyzed a wide array of variables, including demographics (age, gender, BMI), comorbidities (hypertension, diabetes, CRD), tumor characteristics (size, consistency, Knosp grade), and surgical factors (extent of resection and reconstruction techniques like vascularized flaps).
Results
Intraoperative Risk Factors
Intraoperative CSF leaks occurred in 32.0% of the cohort. Univariate analysis identified tumor size and BMI as significant factors. Subsequent multivariate analysis confirmed that tumor size was the only independent predictor for intraoperative leaks (OR 1.229, p < 0.001).
Postoperative Risk Factors
Postoperative leaks were rarer, occurring in 3.6% of patients. The analysis revealed a "cascade of risk": patients who leaked during the procedure were over seven times more likely to experience a postoperative leak. Furthermore, Chronic Respiratory Disease (CRD) showed a massive correlation with postoperative leaks (OR 57.500, p < 0.001).
Crucially, the use of a Vascularized Nasal Septal Flap (VNSF) emerged as a powerful protective measure, significantly decreasing the risk of postoperative rhinorrhea (OR 0.107, p = 0.039).
Discussion
The findings suggest a "thinning effect" where larger tumors stretch the diaphragma sellae, making it highly susceptible to rupture during surgery. The connection between CRD and postoperative leaks is likely mechanical; coughing or labored breathing increases intracranial pressure, which can physically dislodge surgical repair materials.
Interestingly, while postoperative lumbar subarachnoid drains are common, this study found they had no significant effect on preventing leaks. Instead, the VNSF—a living tissue graft with its own blood supply—proved to be the superior tool for durable skull base reconstruction.
Conclusion
Intraoperative CSF leakages are more likely to occur in large pituitary adenomas, and their presence significantly predisposes patients to postoperative complications. Patients with chronic respiratory disease are at particularly high risk. However, reconstructing the sellar base using vascularized nasal septal flaps can significantly decrease these risks, providing a more reliable seal than traditional methods.
Summary updated